Synergistic control mechanism for abnormal site phosphorylation of Alzheimer′s diseased brain tau by kinase FA/GSK-3α

  • Shiaw Der Yang*
  • , Jau Song Yu
  • , Wan Kyng Liu
  • , Shu Hui Yen
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

14 Scopus citations

Abstract

When a synthetic peptide fragment (VAVVRTPPKSPSSAK) which corresponds to amino acid residues 226-240 from brain microtubule-associated protein tau was used as a testing substrate, we found that protein kinase FA/GSK-3α was almost inactive towards this substrate. In sharp contrast, when Ser-10 of this peptide was replaced by a phosphoserine, the phosphopeptide fragment (VAVVRTPPKS(p)PS S A K) became an excellent substrate for kinase FA/GSK-3α. Sequential manual Edman degradation together with phosphoamino acid analysis and protein sequencing further revealed that Thr-6 of the peptide fragment which corresponds to an important abnormal phosphorylation site Thr-231 in Alzheimer′s diseased brain tau was the only site that was greatly phosphorylated, demonstrating that a pre-phosphorylation becomes a prerequisite and is essential for promoting phosphorylation of Thr-231. Taken together, the results provide initial evidence that kinase FA/GSK-3α mediates a synergistic phosphorylation control mechanism involved in the abnormal site phosphorylation of Alzheimer′s diseased brain tau.

Original languageEnglish
Pages (from-to)400-406
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume197
Issue number2
DOIs
StatePublished - 15 12 1993

Fingerprint

Dive into the research topics of 'Synergistic control mechanism for abnormal site phosphorylation of Alzheimer′s diseased brain tau by kinase FA/GSK-3α'. Together they form a unique fingerprint.

Cite this